Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus formulation and azole interaction study in transplant recipients
NL-OMON28458Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2021
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tacrolimus, fluconazole and voriconazole in mycoses (2 cohorts), sponsored by University Medical Center Groningen. Primary endpoint: Dose-adjusted increase in AUC of IR-Tac and ER-Tac. Started Jun 2021; status: recruiting.
02
Drugs
tacrolimusfluconazolevoriconazole
03
Conditions
mycoses
Beyond the preview
Go deeper on NL-OMON28458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28458.